New ALS drug QRL-201 enters human safety testing
Disease control
Ongoing
This early-stage study tests whether a new drug called QRL-201 is safe and tolerable for people with ALS (Lou Gehrig's disease). About 69 adults aged 18-80 with recent ALS symptoms will receive either the drug or a placebo. The main goal is to check for side effects, not to cure …
Phase: PHASE1 • Sponsor: QurAlis Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC